In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Nebulizer Market Report

The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025.

The global nebulizer market is one of the steady growing segments in the global medical devices market. It is expected to grow at a healthy pace during the forecast period. This surge can be attributable to the growing prevalence of asthma, chronic obstructive pulmonary disease (COPD) patients, cystic fibrosis, and the outbreak of the COVID-19 pandemic. The rising incidence of chronic respiratory diseases is increasing the demand for nebulizers at a significant rate over the past few years across the globe. According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.

The rise in COVID-19 cases across the globe has increased the demand for nebulizers. The device’s usage to treat the coronavirus affected patients is growing during the COVID-19 pandemic. According to the WHO, more than 180 countries are affected by COVID-19. Italy, Spain, the UK, the US, China, France, Spain, Iran, Germany, the Netherlands, and Belgium accounted for more than 75% of the cases. With 20% to 40% and 5% to 15% of COVID-19 patients requiring hospitalization and intensive/emergency care, the demand for medical ventilators and nebulizers to deliver medication directly to the lungs is likely to grow phenomenally between 2020 and 2021.

The following factors are likely to contribute to the growth of the nebulizer market during the forecast period:

  • High Demand for Mesh Nebulizers
  • COVID-19 Fueling Surge in Nebulizers
  • Growing Popularity of Home Nebulization
  • Favorable Patient Demographics

The study considers the present scenario of the nebulizer market and its market dynamics for the period 2019?2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Global Nebulizer Market Segmentation
The global nebulizer market research report includes a detailed segmentation by products, portability, end-user, and geography. Jet nebulizers are widely drug delivery machines across the globe. The segment accounts for the largest market revenue. However, it is likely to decline on account of the growing popularity and adoption of mesh devices. An important driver, which is influencing their usage, is the effectiveness in delivering formulations that cannot be delivered with pressurized metered-dose and dry powder inhalers. However, these devices are incorporated with ventilators to synchronize aerosol delivery with inspiration, maintain constant tidal volume, and avoid drug waste. This factor has increased the usage of jet type in ICUs to treat critically ill patients.

The tabletop devices segment is likely to retain its dominance; however, portable nebulizers are expected to grow at the highest CAGR during the forecast period. The usage of tabletop devices in emergency care and home healthcare settings is increasing their application world over. The resistance to change to the latest inhaling technology in the elderly population is helping to consolidate the segment. The tabletop segment is likely to witness an absolute growth of over 36% and an incremental growth of around $173.6 million during the forecast period.

In 2019, the hospital segment accounted for a share of 54% in the global nebulizer market. The increase in the number of hospitals offering treatment to several patient groups requiring nebulizers. For decades, hospitals have been the first point of contact for emergencies from asthma, COPD, and other respiratory disorders. The rising geriatric population is fueling the hospital segment.

Home healthcare settings are witnessing a high demand for nebulizers. The COVID-19 pandemic situation has changed the patient pathway for the treatment of diseases. Several COPD and asthma patients are diverted to home healthcare settings. To prevent the spread of the virus, the majority of the respiratory patients are diverted to home healthcare devices in developed countries. These factors are driving the demand for nebulizers across home healthcare settings.

Segmentation by Products

  • Jet
  • Mesh
  • Ultrasonic

Segmentation by Portability

  • Tabletop
  • Portable

Segmentation by End-user

  • Hospitals
  • Home Healthcare
  • Others

Insights by Geography

The North American market is growing at a moderate rate. Although the region is expected to grow at a slower rate than other regions, the COVID-19 pandemic has fueled a surge in nebulizers in the region, especially in the US. The country will witness a positive growth as national health spending is projected to grow at an average annual rate of 5.4% for 2019–2028, reaching $6.2 trillion by 2028. North America experienced a large-scale adoption of nebulizers over the past decade. The rise in pollution rates, along with the growing number of cases related to respiratory troubles, even for neo-natal care, is one of the major reasons that has boosted the overall demand in North America. However, the COVID-19 pandemic situation has affected North America drastically. The number of people affected by COVID-19 is on the higher side; more than lakh people are affected by the coronavirus. A large number of people are admitted to emergency rooms and are on ventilators.

Segmentation by Geography

  • North America

o US
o Canada

  • Europe

o UK
o Germany
o France
o Italy
o Spain

  • APAC

o China
o Japan
o South Korea
o Australia
o India

  • Latin America

o Brazil
o Mexico
o Argentina

  • Middle East & Africa

o South Africa
o Saudi Arabia
o Turkey

Insights by Vendors
The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices. OMRON, Koninklijke Philips, Drive DeVilbiss International, PARI, Feellife Health, Besco Medical, and Rossmax International, and Ca-Mi are the key market players dominating the market. Although the large vendors dominate, they are witnessing heavy competition from regional and local companies from India, China, Italy, and Germany. Many regional vendors also are offering cost-effective nebulizers in Europe, APAC, and the Middle East & Africa regions.

Prominent Vendors


o Business Overview
o Product Offerings
o Key Strengths
o Key Strategies
o Key Opportunities

  • Koninklijke Philips
  • Drive Devilbiss Healthcare
  • Besco Medical
  • PARI
  • Rossmax International
  • Feellife Health
  • CA-MI

Other Prominent Vendors

  • Liquide Medical Systems

o Business Overview
o Product Offerings

  • Allied Healthcare Products
  • Andreas Fahl Medizintechnik-Vertrieb
  • AME Group
  • Babybelle
  • Big Eagle
  • Bremed
  • Well Swiss
  • DELBio
  • EP S.p.A
  • Flexicare
  • Fazzini
  • H?nkar Ecza ve Medikal
  • Little Doctor International
  • MED2000
  • San-Up
  • HELTMAN Medikal
  • Jiangsu Dengguan Medical Treatment Instrument
  • Medpack Swiss Group
  • Microlife
  • MTD Medical Technology and Devices
  • Norditalia Group
  • Promed Group
  • Tai Yu International Manu
  • Trimpeks
  • Vega Technologies
  • Wuhan W.E.O. Science & Technology Development
  • Westmed
  • Compass Health Brands
  • Koo Medical Equipment
  • Sunset Healthcare Solutions
  • Morepen Laboratories
  • Trudell Medical International


  • What is the nebulizer market size and growth rate during the forecast period?
  • How is the growth of healthcare infrastructure supporting the growth trend of the nebulizer market in the North America region?
  • Which product/portability/end-user segment is generating the largest revenues for the market?
  • What are the factors leading to the growth of regional vendors in the nebulizer market?
  • What is the impact of the COVID-19 pandemic on the European nebulizer market?